NYSE: AVTR

Avantor (AVTR) Stock Analysis & Forecast

Nov 13 close

$15.54−0.08 (−0.5%)

Gekko Brief

Nov 9 close

Avantor closed at $15.91 on 9 November 2026, +2.8% on the day. The price sits above both the 50-day ($15.62) and 200-day ($11.30) moving averages, inside a 52-week range of $7.27 to $17.45. The GekkoIndex reads 60.6, in the Accumulation zone, up 1.8 points over five sessions. Gekko Fair Value is $18.05, so the price is 11.9% below it.

The next earnings report is due on 10 February 2027, 87 days away (before open). Over the last 8 reports the company beat the earnings estimate 5 times, with an average move of 13.7% across the report. Seasonally, the next 20 trading days from this point averaged +1.6% over the last 5 years, rising in 3 of them.

14 firms rate the stock: 2 buy, 11 hold and 1 sell, with a consensus target of $17.35. A typical daily move is about 3.7%, and a typical 20-day move about 5.9%. On the swing-trade checklist, 5 items read supportive and 0 read as a headwind.

A plain summary of the figures as of the Nov 9, 2026 close.

Avantor price vs fair value

$17.22$15.54Nov ’25May ’26Nov ’26
Close $15.54200-day averageGekko Fair Value $17.22

Avantor quick facts

Market cap
$10.53B
P/E ratio
31.2
Forward P/E
17.9
EPS, TTM
$0.50
Revenue, TTM
$6.64B
Profit margin
5.1%
Dividend yield
—
Beta
0.95
Volume
6.82M avg 9.50M
1-year return
+34.5%
Typical daily move
±3.6%
Typical 20-day move
±5.9%
50-day average
$15.70
200-day average
$11.39
Next earnings
Feb 10 before open
Shares outstanding
677.6M
52-week range
$7.27$17.45

Avantor swing-trade checklist

Avantor scores 4 supportive, 1 mixed and 0 headwinds across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

4 supportive1 mixed0 headwinds

  • Trendmixed

    Averages disagree

    Close $15.54 sits between the 50-day ($15.70) and 200-day ($11.39) averages, or the averages disagree.

    See the chart
  • GekkoIndexsupportive

    61.7, Accumulation

    Reading 61.7 is in the Accumulation zone.

    See the GekkoIndex
  • Fair valuesupportive

    9.8% below

    Price is 9.8% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 87 days

    Next report Feb 10, 2027, 87 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitysupportive

    +4.9% on average

    From this point in the calendar, the next 20 trading days averaged +4.9% over 5 years, rising in 3 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Avantor stock chart and price history

Avantor closed at $15.54 on Nov 13, 2026, +34.5% over the past year, inside a 52-week range of $7.27 to $17.45.

Close50-day average200-day averageVolume
Avantor share price, past year, with 50-day and 200-day moving averages and volume$8$10$12$14DecJan 2026FebMarAprMayJunJulAugSepOctNov15.54

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
−3.4%
3 months
+15.1%
6 months
+103.9%
1 year
+34.5%
The full AVTR chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open AVTR in Gekko

Follow Avantor through every session

Put AVTR on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track AVTR in GekkoFree for 7 days. No credit card required.

About Avantor

Avantor equips labs and production facilities with the materials, tools and expertise they need to operate day to day. Its catalog stretches from high-purity chemicals, reagents and general lab supplies to custom silicone formulations, tailored excipients, single-use assemblies, chromatography resins and columns, sample prep kits, clinical trial kits and fluid handling tips. It also sells instruments like ultra-low-temperature freezers, incubators, biological safety cabinets, evaporators, and systems for filtration and virus inactivation, giving it a footprint that runs from small consumables to larger lab hardware.

On top of these products, Avantor offers services that help customers run their own sites, including on-location lab and production support, clinical services, equipment upkeep, sourcing and procurement help, and assistance developing and scaling biopharmaceutical materials. It works with biopharmaceutical and broader healthcare organizations, schools and universities, government bodies, technology firms, and companies in applied materials. Its reach extends across the Americas, Europe, Asia, and parts of the Middle East and Africa.

The company dates back to 1904 and keeps its headquarters in Radnor, Pennsylvania. Avantor trades on the NYSE under the ticker AVTR.

Listed
NYSE
Sector
Health technology
Industry
Medical specialties
Website
avantorsciences.com

Avantor GekkoIndex: the smart money zone

Avantor’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 61.7, in the Accumulation zone, down 1.8 points over five sessions.

010061.7Accumulation

Down 1.8 points over five sessions.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying80−0.9%−1.9%−2.1%−2.1%
Accumulation (current zone)241+0.4%0.0%+0.3%−1.2%
Neutral351−0.1%+0.3%−0.5%−1.5%
Distribution28−0.7%−0.6%+4.8%+11.9%
Selling2Too few readings yet

Average AVTR share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.

Accumulation zone: Institutional interest building. About the five zones →

See every daily GekkoIndex reading plotted over the AVTR price, zone by zone.Track AVTR in Gekko

Is Avantor stock overvalued? Gekko Fair Value

Avantor trades 9.8% below Gekko Fair Value of $17.22, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Avantor shares are worth, recalculated every trading day.

$17.22

Gekko Fair Value, Nov 14, 2026

9.8% Undervalued

At the end of Aug 2026 the price was 17.7% below the estimate.

Gekko Fair ValueShare price, month end
$17$16Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open AVTR in Gekko

Avantor insider and Congress trading

No open-market insider purchases were filed for Avantor, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for AVTR in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every AVTR insider filing, plotted on the chart in Gekko.Open AVTR in Gekko

Congress trades last 90 days

No trades in AVTR were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for AVTR, plotted on the chart in Gekko.Open AVTR in Gekko

Buybacks

Avantor has been buying back its own shares.

Bought back, quarter ended Jun 30, 2026
$300K
As a share of market cap
0.00%
Trailing four quarters
$79.60M

From company filings.

Hedge funds and billionaires quarter ended Jun 30

4of the funds Gekko tracks hold AVTR.

2added1opened1trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko

Avantor earnings: next date and track record

Avantor reports on Feb 10, 2027, before the open (87 days away), and beat the EPS estimate in 5 of its last 8 reports.

5 of 8reports beat the EPS estimate
±13.7%average move across the report
2 of 8reports followed by a gain

Share-price move across each report

−12.4%Feb ’25−19.4%Apr ’25−15.9%Aug ’25−26.7%Oct ’25−18.1%Feb ’26+3.1%Apr ’26+11.6%Jul ’26−2.6%Oct ’26

Last earnings call, Oct 28, 2026 AI summary

What they said
Avantor reported Q3 2026 revenue of $1.698 billion, representing 5.2% organic growth and 4.6% reported growth, exceeding expectations. VWR services segment accelerated to 5.8% organic growth, while Bioscience & Med Tech Products (BMP) returned to growth at 3.6% organically. Adjusted EPS of $0.22 beat expectations, and free cash flow reached $169 million. Adjusted net leverage ratio stands at 3.1x, with sub-3x target expected by year-end.
Guidance
Management raised full-year 2026 guidance for organic revenue growth, adjusted EPS, and free cash flow, citing Q3 outperformance and improving end-market momentum. BMP segment is positioned for growth in 2027 and beyond as Revival initiatives gain traction.
ReportedEPSSurpriseRevenueSurpriseMove
Oct 28, 2026$0.22
est $0.21
+5.3%$1.70B
est $1.64B
+3.4%−2.6%
Jul 29, 2026$0.21
est $0.19
+9.7%$1.69B
est $1.61B
+5.1%+11.6%
Apr 29, 2026$0.17
est $0.16
+6.3%$1.58B
est $1.54B
+2.5%+3.1%
Feb 11, 2026$0.22
est $0.21
+4.8%$1.66B
est $1.64B
+1.6%−18.1%
Oct 29, 2025$0.22
est $0.22
−2.1%$1.62B
est $1.65B
−1.3%−26.7%
Aug 1, 2025$0.24
est $0.25
−4.0%$1.68B
est $1.65B
+2.3%−15.9%
Apr 25, 2025$0.23
est $0.23
−0.6%$1.58B
est $1.61B
−1.6%−19.4%
Feb 7, 2025$0.27
est $0.25
+8.0%$1.69B
est $1.66B
+1.4%−12.4%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Avantor stock forecast and analyst price targets

Analysts’ average 12-month price target for Avantor is $17.35, +11.6% from the last close, from 14 firms rating the stock in the last 90 days.

$17.35consensus 12-month target, +11.6% from the last close
Low $15High $18
Buy2
Hold11
Sell1

Each firm’s latest rating in the last 90 days: 14 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 13BernsteinHold, maintained——
Oct 29BarclaysSell, maintained$16+3.0%
Oct 29Stifel NicolausHold, maintained$18+15.8%
Oct 29Deutsche Bank Hold, maintained$17+9.4%
Oct 29Stifel NicolausHold, reiterated$18+15.8%
+0.3%average 20-day move after past Accumulation readings
+4.9%average move over the next 20 trading days in the last 5 years
±3.6%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Avantor seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, Avantor averaged +4.9% across the last 5 years, rising in 3 of them.

Next 20 trading days, by year

−0.4%2021+4.6%2022+16.7%2023+5.6%2024−0.9%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days+0.4%3 of 5
Next 10 trading days+3.1%4 of 5
Next 15 trading days+1.4%3 of 5
Next 20 trading days+4.9%3 of 5
Next 30 trading days+5.4%3 of 5

For scale, AVTR’s typical 20-trading-day move in either direction is about 5.9%.

Avantor market cap and key statistics

Avantor’s market cap is $10.53B, with a P/E ratio of 31.2 and revenue of $6.64B over the last twelve months.

Valuation

Market cap
$10.53B
P/E ratio
31.2
Forward P/E
17.9
EPS, TTM
$0.50
Gekko Fair Value
$17.22

Trading

Volume
6.82M
Avg volume, 20 days
9.50M
52-week high
$17.45
52-week low
$7.27
Shares outstanding
677.6M

Financials

Revenue, TTM
$6.64B
Profit margin
5.1%
Return on equity
5.9%
Quarterly earnings growth, YoY
−37.4%

Risk and income

Beta
0.95
Typical daily move
±3.6%
Typical 20-day move
±5.9%

Avantor stock news this week

Coverage of Avantor this week reads positive: 2 positive, 2 neutral and 0 negative headlines.

News sentiment positive

Avantor peers

Avantor’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
TMOThermo Fisher Scientific−0.2%Neutral15.0% above
ABTAbbott Laboratories+0.3%Neutral10.5% below
DHRDanaher0.0%Neutral4.7% above
ISRGIntuitive Surgical0.0%Neutral17.5% above
MDTMedtronic+0.7%Neutral14.2% below
SYKStryker−2.0%Neutral0.1% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Medical specialties

Avantor stock FAQ

What is Avantor’s market cap?

Avantor’s market cap is $10.53B at the Nov 13, 2026 close of $15.54, with 677.6M shares outstanding. The shares trade on a P/E ratio of 31.2.

What is the Avantor stock forecast?

The consensus analyst 12-month price target for Avantor is $17.35, +11.6% from the last close. Of the 14 firms that rated the stock in the last 90 days, 2 rate it a buy, 11 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.

Is Avantor stock overvalued or undervalued?

On Gekko’s estimate Avantor is undervalued: the Nov 13, 2026 close of $15.54 is 9.8% below Gekko Fair Value of $17.22. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Avantor report earnings next?

Avantor is expected to report on Feb 10, 2027, before the market opens (87 days away). Analysts expect earnings of $0.22 per share on revenue of $1.70B. Avantor beat the earnings estimate in 5 of its last 8 reports, moving 13.7% on average across the report.

What is Avantor’s 52-week high and low?

Avantor’s 52-week high is $17.45 and its 52-week low is $7.27; it closed at $15.54 on Nov 13, 2026, +34.5% over the past year. Over the last five years the shares peaked at $42.48 on Dec 31, 2021.

Is Avantor stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (gekkoindex, fair value, earnings risk and seasonality), 1 as mixed (trend). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Avantor the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.